Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by enalapril (MK-421): A new angiotensin-converting enzyme inhibitor
- 1 July 1983
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 32 (7) , 711-716
- https://doi.org/10.1016/0026-0495(83)90129-4
Abstract
No abstract availableFunding Information
- U.S. Public Health Service (5-T3, I-T30-Ah421683)
This publication has 22 references indexed in Scilit:
- Thiazide diuretics, Hypokalemia and Cardiac ArrhythmiasActa Medica Scandinavica, 1981
- Potassium Maintenance Potassium Supplements or Potassium Sparing AgentsActa Medica Scandinavica, 1981
- A new class of angiotensin-converting enzyme inhibitorsNature, 1980
- IMMUNE-COMPLEX GLOMERULOPATHY IN PATIENTS TREATED WITH CAPTOPRILThe Lancet, 1980
- Increased Glomerular Filtration Rate after Converting-Enzyme Inhibition in Essential HypertensionNew England Journal of Medicine, 1979
- Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis.Hypertension, 1979
- Accentuated Vascular and Endocrine Response to Sq 20881 in HypertensionNew England Journal of Medicine, 1977
- The measurement of urinary tetrahydroaldosterone by radioimmunoassayThe Journal of Steroid Biochemistry and Molecular Biology, 1977
- Renin-Angiotensin-Aldosterone System During Chronic Thiazide Therapy of Benign HypertensionCirculation, 1968
- New Tables for Multiple Comparisons with a ControlPublished by JSTOR ,1964